| Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC X Bao, R Shi, T Zhao, Y Wang, N Anastasov, M Rosemann, W Fang Cancer Immunology, Immunotherapy 70, 189-202, 2021 | 121 | 2021 |
| E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle J Sun, R Shi, S Zhao, X Li, S Lu, H Bu, X Ma, C Su Journal of Experimental & Clinical Cancer Research 36, 1-14, 2017 | 72 | 2017 |
| Radiotherapy of oligometastatic prostate cancer: a systematic review P Rogowski, M Roach, NS Schmidt-Hegemann, C Trapp, ... Radiation Oncology 16, 1-16, 2021 | 68 | 2021 |
| Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients R Shi, X Bao, K Unger, J Sun, S Lu, F Manapov, X Wang, C Belka, M Li Theranostics 11 (10), 5061, 2021 | 67 | 2021 |
| Dual hypoxia-targeting RNAi nanomedicine for precision cancer therapy Y Li, J Ding, X Xu, R Shi, PE Saw, J Wang, S Chung, W Li, BM Aljaeid, ... Nano letters 20 (7), 4857-4863, 2020 | 58 | 2020 |
| ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression X Wang, Q Sun, C Chen, R Yin, X Huang, X Wang, R Shi, L Xu, B Ren Oncotarget 7 (7), 8029, 2016 | 58 | 2016 |
| A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis Y Wang, Q Zhang, Z Gao, S Xin, Y Zhao, K Zhang, R Shi, X Bao Cancer cell international 19, 1-9, 2019 | 53 | 2019 |
| Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma X Bao, R Shi, T Zhao, Y Wang Molecular oncology 14 (5), 917-932, 2020 | 52 | 2020 |
| Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients J Sun, T Zhao, D Zhao, X Qi, X Bao, R Shi, C Su Therapeutic advances in medical oncology 12, 1758835920937904, 2020 | 51 | 2020 |
| Prognostic and predictive value of three DNA methylation signatures in lung adenocarcinoma Y Wang, H Deng, S Xin, K Zhang, R Shi, X Bao Frontiers in genetics 10, 349, 2019 | 48 | 2019 |
| DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma W Xia, Q Chen, J Wang, Q Mao, G Dong, R Shi, YY Zheng, L Xu, F Jiang Scientific reports 5 (1), 16901, 2015 | 48 | 2015 |
| Cell division cycle 45 promotes papillary thyroid cancer progression via regulating cell cycle J Sun, R Shi, S Zhao, X Li, S Lu, H Bu, X Ma Tumor Biology 39 (5), 1010428317705342, 2017 | 43 | 2017 |
| CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients R Shi, C Zhang, Y Wu, X Wang, Q Sun, J Sun, W Xia, G Dong, A Wang, ... Oncotarget 8 (12), 19768, 2017 | 40 | 2017 |
| Immune landscape of invasive ductal carcinoma tumor microenvironment identifies a prognostic and immunotherapeutically relevant gene signature X Bao, R Shi, K Zhang, S Xin, X Li, Y Zhao, Y Wang Frontiers in oncology 9, 903, 2019 | 39 | 2019 |
| Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non–small cell lung cancer R Shi, X Yu, Y Wang, J Sun, Q Sun, W Xia, G Dong, A Wang, Z Gao, ... Tumor Biology 39 (4), 1010428317695928, 2017 | 37 | 2017 |
| Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy J Sun, R Shi, X Zhang, D Fang, J Rauch, S Lu, X Wang, L Käsmann, J Ma, ... Oncoimmunology 10 (1), 1964189, 2021 | 35 | 2021 |
| APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases R Shi, X Wang, Y Wu, B Xu, T Zhao, C Trapp, X Wang, K Unger, C Zhou, ... Theranostics 12 (9), 4181, 2022 | 33 | 2022 |
| Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower‐Grade Gliomas Y Wang, S Xin, K Zhang, R Shi, X Bao Journal of oncology 2019 (1), 1785042, 2019 | 31 | 2019 |
| Overexpression of ZIC5 promotes proliferation in non-small cell lung cancer Q Sun, R Shi, X Wang, D Li, H Wu, B Ren Biochemical and biophysical research communications 479 (3), 502-509, 2016 | 31 | 2016 |
| Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies W Xia, Y Xu, Q Mao, G Dong, R Shi, J Wang, YY Zheng, L Xu, F Jiang Medical Oncology 32, 1-9, 2015 | 29 | 2015 |
